Search Results 1021-1030 of 15957 for Residual

1. A Study to Evaluate the Effectiveness and Safety of G10 in Subjects with Transthyretin Amyloid Cardiomyopathy - Mayo Clinic

   Participation in another investigational drug or investigational device study within 30 days prior to dosing with potential residual effects that might confound ...

2. Publications - Moritz Binder, M.D., M.P.H. - Mayo Clinic

   Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms. Blood Cancer J 2024 Jul 31; 14 (1):126 Epub 2024 July ...

3. Dr. Paul Brown Archives - Mayo Clinic News Network

   ... residual cancer and results in fewer cognitive problems and better quality of life than whole-brain radiotherapy, according to the results of a phase III ...

4. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

   subject with history of adequately treated malignancy for which the subject has been disease free (absence of residual disease) for at least 1 year and if ...

5. Phase III Study Of Datopotamab Deruxtecan Versus Docetaxel In Previously Treated TROP2-positive Advanced Non-squamous NSCLC Without AGA - Mayo Clinic

   Residual toxicities from prior immunotherapy treatment: Grade 1 or Grade 2 endocrinopathies, which may include but are not limited to hypothyroidism ...

6. Bevacizumab with or without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients with Recurrent Glioblastoma Multiforme - Mayo Clinic

   ... residual disease on postoperative imaging or if there is imaging evidence of disease progression as compared to the first postoperative scan; Measurable or ...

7. Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma - Mayo Clinic

   Patients must have ≤ 1.5 cm2 maximal cross-sectional area of residual tumor (see Section 3.1.4). Whole brain MRI with and without gadolinium and spine MRI ...

8. Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder - Mayo Clinic

   For non-catheterizing subjects, post-void residual is > 100 mL measured by bladder ultrasound, bladder scanner, or one-time catheterization at the time of ...

9. Publications - Laura E. Raffals, M.D. - Mayo Clinic

   Causes, Diagnostic Testing, and Treatment of Residual Symptoms in Patients With IBD With Quiescent Disease. Am J Gastroenterol. 2023 Nov 1; 118 (11):1909 ...

10. Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery - Mayo Clinic

    ... residual disease after surgery are not eligible; A paraffin-embedded surgical tumor tissue specimen has been located is available for shipment to Foundation ...